A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells

Area of Science:

• Immunotherapy
• Cellular Therapy
• Oncology

Background:

• Chimeric antigen receptor (CAR)-natural killer (NK) cells offer potential advantages over CAR-T cells for B-cell malignancies and autoimmune diseases.
• Current methods for CAR-NK cell generation often rely on feeder cells from cancerous tissue, posing safety concerns.
• Standardized and scalable methods for producing clinical-grade CAR-NK cells are needed.

Purpose of the Study:

• To develop a feeder-free method for large-scale ex vivo expansion of anti-CD19 CAR-NK cells.
• To enable efficient genetic modification of expanded NK cells using retroviral vectors.
• To establish a safer protocol for clinical application of CAR-NK cell therapy.

Main Methods:

• Expansion of primary human NK cells from peripheral blood mononuclear cells using CD2- and NKp46-specific stimulating antibodies and multiple cytokines.
• Genetic modification of activated NK cells with a retroviral vector encoding anti-CD19 CAR.
• Feeder-free culture conditions to eliminate the need for tumor-derived feeder cells.

Main Results:

• Successful large-scale generation of anti-CD19 CAR-NK cells without feeder cells.
• Efficient gene transfer into NK cells stimulated with the described antibody and cytokine cocktail.
• Minimal gene transfer into T cells, even without cell sorting.

Conclusions:

• The described method provides a feeder-free, scalable approach for generating anti-CD19 CAR-NK cells.
• This protocol enhances the safety profile by avoiding tumor cell contamination.
• The method facilitates the clinical translation of CAR-NK cell therapy for B-cell malignancies and autoimmune diseases.